Related Experiment Video
Updated: May 31, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Dose-dependent effects of the caspase inhibitor Q-VD-OPh on different apoptosis-related processes
Kateřina Kuželová1, Dana Grebeňová, Barbora Brodská
1Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 2, 128 20 Prague 2, Czech Republic. katerina.kuzelova@uhkt.cz
Abstract:
The effects of the pan-caspase inhibitor Q-VD-OPh on caspase activity, DNA fragmentation, PARP cleavage, 7A6 exposition, and cellular adhesivity to fibronectin were analyzed in detail in three different apoptotic systems involving two cell lines (JURL-MK1 and HL60) and two apoptosis inducers (imatinib mesylate and suberoylanilide hydroxamic acid). Q-VD-OPh fully inhibited caspase-3 and -7 activity at 0.05 µM concentration as indicated both by the measurement of the rate of Ac-DEVD-AFC cleavage and anti-caspase immunoblots. Caspase-8 was also inhibited at low Q-VD-OPh concentrations. On the other hand, significantly higher Q-VD-OPh dose (10 µM) was required to fully prevent the cleavage of PARP-1. DNA fragmentation and disruption of the cell membrane functionality (Trypan blue exclusion test) were both prevented at 2 µM Q-VD-OPh while 10 µM inhibitor was needed to inhibit the drug-induced loss of cellular adhesivity to fibronectin which was observed in JURL-MK1 cells. The exposition of the mitochondrial antigen 7A6 occurred independently of Q-VD-OPh addition and may serve to the detection of cumulative incidence of the cells which have initiated the apoptosis. Our results show that Q-VD-OPh efficiency in the inhibition of caspase-3 activity and DNA fragmentation in the whole-cell environment is about two orders of magnitude higher than that of z-VAD-fmk. This difference is not due to a slow permeability of the latter through the cytoplasmic membrane.
Insights
The pan-caspase inhibitor Q-VD-OPh effectively blocks caspase activity and DNA fragmentation at low concentrations. It also prevents PARP cleavage and preserves cell membrane integrity during apoptosis.
Area of Science:
- Biochemistry and Molecular Biology
- Cell Biology
- Pharmacology
Background:
- Apoptosis is a crucial biological process involving caspases.
- Pan-caspase inhibitors are vital tools for studying apoptosis.
- Q-VD-OPh is a potent inhibitor with potential therapeutic applications.
Purpose of the Study:
- To comprehensively evaluate the efficacy of Q-VD-OPh in inhibiting various apoptotic markers.
- To compare Q-VD-OPh with another pan-caspase inhibitor, z-VAD-fmk.
- To investigate the dose-dependent effects of Q-VD-OPh on cellular processes during apoptosis.
Main Methods:
- Analysis of caspase-3, -7, and -8 activity using fluorometric assays and immunoblots.
- Assessment of Poly (ADP-ribose) polymerase (PARP-1) cleavage.
- Evaluation of DNA fragmentation and cell membrane integrity (Trypan blue exclusion test).
- Measurement of cellular adhesivity to fibronectin.
- Utilized JURL-MK1 and HL60 cell lines with imatinib mesylate and suberoylanilide hydroxamic acid as apoptosis inducers.
Main Results:
- Q-VD-OPh potently inhibited caspase-3 and -7 activity at 0.05 µM and caspase-8 at low concentrations.
- Higher concentrations (10 µM) of Q-VD-OPh were required for complete PARP-1 cleavage inhibition.
- DNA fragmentation and cell membrane dysfunction were prevented at 2 µM Q-VD-OPh.
- Q-VD-OPh (10 µM) inhibited drug-induced loss of fibronectin adhesion in JURL-MK1 cells.
- Mitochondrial antigen 7A6 exposition occurred independently of Q-VD-OPh, suggesting its use in detecting early apoptotic events.
- Q-VD-OPh demonstrated significantly higher efficiency than z-VAD-fmk in inhibiting caspase-3 and DNA fragmentation.
Conclusions:
- Q-VD-OPh is a highly effective pan-caspase inhibitor with superior potency compared to z-VAD-fmk.
- Its efficacy spans multiple apoptotic pathways, including caspase activation, DNA fragmentation, and PARP cleavage.
- Q-VD-OPh preserves cellular integrity and adhesion during apoptosis, highlighting its potential in therapeutic strategies targeting apoptotic processes.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...

